{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:21:27Z","timestamp":1774084887499,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Current Review of Pain"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s11916-000-0066-7","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T16:03:40Z","timestamp":1344441820000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The cancer patient with chronic pain due to herpes zoster"],"prefix":"10.1007","volume":"4","author":[{"given":"Shanu","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,12,1]]},"reference":[{"key":"66_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJM199607043350107","volume":"335","author":"RG Kost","year":"1996","unstructured":"Kost RG, Straus SE: Postherpetic neuralgia\u2014pathogeneis, treatment, and prevention. N Engl J Med 1996, 335:32\u201342.","journal-title":"N Engl J Med"},{"key":"66_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","volume":"130","author":"JI Cohen","year":"1999","unstructured":"Cohen JI, Brunell PA, Straus SE, Krause PR: Recent advances in varicella-zoster virus infection. Ann Intern Med 1999, 130:922\u2013932.","journal-title":"Ann Intern Med"},{"key":"66_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0190-9622(99)70398-1","volume":"41","author":"ML McCrary","year":"1999","unstructured":"McCrary ML, Severson J, Tyring SK: Varicella zoster virus. J Am Acad Dermatol 1999, 41:1\u201316.","journal-title":"J Am Acad Dermatol"},{"key":"66_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1988.00380070065016","volume":"148","author":"JJ Rusthoven","year":"1988","unstructured":"Rusthoven JJ, Ahlgren P, Elhakim T, et al.: Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 1988, 148:1561\u20131566.","journal-title":"Arch Intern Med"},{"key":"66_CR5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","volume":"74","author":"LM Schuchter","year":"1989","unstructured":"Schuchter LM, Wingard JR, Piantadosi S, et al.: Herpes zoster infection after autologous bone marrow transplantation. Blood 1989, 74:1424\u20131427.","journal-title":"Blood"},{"key":"66_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000060319","volume":"3","author":"CPN Watson","year":"1999","unstructured":"Watson CPN: Postherpetic neuralgia. Contrib Microbiol 1999, 3:128\u2013140.","journal-title":"Contrib Microbiol"},{"key":"66_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/07357909709115769","volume":"15","author":"KJ Elliot","year":"1997","unstructured":"Elliot KJ: Introduction\u2014postherpetic neuralgia: a treatment dilemma. Cancer Invest 1997, 15:163\u2013164.","journal-title":"Cancer Invest"},{"key":"66_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/07357909709115770","volume":"15","author":"MM Hanania","year":"1997","unstructured":"Hanania MM, Brietstein D: Postherpetic neuralgia: a review. Cancer Invest 1997, 15:165\u2013176.","journal-title":"Cancer Invest"},{"key":"66_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3959(91)90124-G","volume":"44","author":"CPN Watson","year":"1991","unstructured":"Watson CPN, Deck JH, Morshead C, et al.: Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991, 44:105\u2013117.","journal-title":"Pain"},{"key":"66_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3959(88)90158-3","volume":"34","author":"CP Watson","year":"1988","unstructured":"Watson CP, Morshead C, Van der Kooy D, et al.: Post-mortem analysis of a case. Pain 1988, 34:129\u2013138.","journal-title":"Pain"},{"key":"66_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/nbdi.1998.0204","volume":"5","author":"HL Fields","year":"1998","unstructured":"Fields HL, Rowbotham M, Baron R: Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998, 5:209\u2013227. A comprehensive review of the pathophysiology of PHN.","journal-title":"Neurobiol Dis"},{"key":"66_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0924-980X(96)95673-8","volume":"101","author":"M Mondelli","year":"1996","unstructured":"Mondelli M, Romano C, Della Porta P, Rossi A: Electrophysiological findings in peripheral fibres of subjects with and without post-herpetic neuralgia. Electroencephalogr Clin Neurophysiol 1996, 101:185\u2013191.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"66_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF00684037","volume":"2","author":"DH Gilden","year":"1988","unstructured":"Gilden DH, Devlin M, Wellish M, et al.: Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster. Virus Genes 1988, 2:299\u2013305.","journal-title":"Virus Genes"},{"key":"66_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/13550289509111018","volume":"1","author":"R Mahalingham","year":"1995","unstructured":"Mahalingham R, Wellish M, Brucklier J, Gilden DH: Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neuroviol 1995, 1:130\u2013133.","journal-title":"J Neuroviol"},{"key":"66_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/inf.1979.11.issue-1.01","volume":"11","author":"KE Wildenhoff","year":"1979","unstructured":"Wildenhoff KE, Ipsen J, Esmann V, et al.: Treatment of herpes zoster with idoxuridine ointment, including a multivariate analysis of symptoms and signs. Scand J Infect Dis 1979, 11:1\u20139.","journal-title":"Scand J Infect Dis"},{"key":"66_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1128\/AAC.29.3.524","volume":"29","author":"H Machida","year":"1986","unstructured":"Machida H: Comparison of susceptibilites of varicella-zoster virus and herpes simplex viruses to nucleoside analogs. Antimicrob Agents Chemother 1986, 29:524\u2013526.","journal-title":"Antimicrob Agents Chemother"},{"key":"66_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/bmj.4.5738.776","volume":"4","author":"BE Juel-Jensen","year":"1970","unstructured":"Juel-Jensen BE, MacCallum FO, Mackenzie AMR, Pike MC: Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. BMJ 1970, 4:776\u2013780.","journal-title":"BMJ"},{"key":"66_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/bmj.2.5918.526","volume":"2","author":"R Dawber","year":"1974","unstructured":"Dawber R: Idoxuridine in herpes zoster: further evaluation of intermittent topical therapy. BMJ 1974, 2:526\u2013527.","journal-title":"BMJ"},{"key":"66_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/inf.1981.13.issue-4.03","volume":"13","author":"Wildenhoff","year":"1981","unstructured":"Wildenhoff, KE, Esmann V, Ipsen J, et al.: Treatment of trigeminal and thoracic zoster with idoxuridine. Scand J Infect Dis 1981, 13:257\u2013262.","journal-title":"Scand J Infect Dis"},{"key":"66_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJM198210143071602","volume":"307","author":"RJ Whitley","year":"1982","unstructured":"Whitley RJ, Soong SJ, Dolin R, et al.: Early vidarabine therapy to control the complication of herpes zoster in immunosuppressed patients. N Engl J Med 1982, 307:971\u2013975.","journal-title":"N Engl J Med"},{"key":"66_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJM197605272942201","volume":"294","author":"RJ Whitley","year":"1976","unstructured":"Whitley RJ, Chien LT, Dolin R, et al.: Adenosine arabinoside therapy of herpes zoster in the immunosuppressed. N Engl J Med 1976, 294:1193\u20131199.","journal-title":"N Engl J Med"},{"key":"66_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/infdis\/165.3.450","volume":"165","author":"RJ Whitley","year":"1992","unstructured":"Whitley RJ, Gnann JW Jr, Hinthorn D, et al.: Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group\n                  J Infect Dis 1992, 165:450\u2013455.","journal-title":"J Infect Dis"},{"key":"66_CR23","first-page":"69","volume":"78","author":"HH Balfour Jr","year":"1991","unstructured":"Balfour HH Jr: Varicella-zoster virus infections in the immunocompromised host. Scand J Infect Dis 1991, 78(suppl):69\u201374.","journal-title":"Scand J Infect Dis"},{"key":"66_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/BF01651148","volume":"12","author":"PJ Van der Broek","year":"1984","unstructured":"Van der Broek PJ, Van der Meer JWM, Mulder JD, et al.: Limited value of acyclovir in the treatment of uncomplicated herpes zoster: a placebo controlled study. Infection 1984, 12:338\u2013341.","journal-title":"Infection"},{"key":"66_CR25","first-page":"62","volume":"78","author":"RJ Crooks","year":"1991","unstructured":"Crooks RJ, Jones DA, Fiddian AP: Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis 1991, 78(suppl):62\u201368.","journal-title":"Scand J Infect Dis"},{"key":"66_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archinte.1997.00440290095010","volume":"157","author":"JL Jackson","year":"1997","unstructured":"Jackson JL, Gibbons R, Meyer G, Inouye L: The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. Arch Intern Med 1997, 157:909\u2013912.","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"66_CR27","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1086\/514260","volume":"178","author":"RH Dworkin","year":"1998","unstructured":"Dworkin RH, Boon RJ, Griffin DRG, Phung D: Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998, 178(suppl 1):S76\u201380.","journal-title":"J Infect Dis"},{"key":"66_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0924-8579(94)90024-8","volume":"4","author":"H Degreef","year":"1994","unstructured":"Degreef H: Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Famciclovir Herpes Zoster Clinical Study Group. Int J Antimicrob Agents 1994, 4:241\u2013246.","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl 1","key":"66_CR29","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/514271","volume":"178","author":"MJ Wood","year":"1998","unstructured":"Wood MJ, Shukla S, Fiddian AP, Crooks RJ: Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valacyclovir on prolonged pain. J Infect Dis 1998, 178(suppl 1):S81\u201384. A re-analysis of previously collected patient databases demonstrating the efficacy of Valacyclovir and acyclovir in preventing PHN.","journal-title":"J Infect Dis"},{"key":"66_CR30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.42.5.1139","volume":"42","author":"JW Gnann Jr","year":"1998","unstructured":"Gnann JW Jr, Crumpacker CS, Lalezari JP, et al.: Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. CASG\/ACTG Herpes Zoster Study Group. Antimicrob Agents Chemother 1998, 42:1139\u20131145.","journal-title":"Antimicrob Agents Chemother"},{"key":"66_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1365-4362.1990.tb04852.x","volume":"29","author":"BA Lycka","year":"1990","unstructured":"Lycka BA: Postherpetic neuralgia and systemic corticosteroid therapy\u2014efficacy and safety. Int J Dermatol 1990, 29:523\u2013527.","journal-title":"Int J Dermatol"},{"key":"66_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0190-9622(88)70082-1","volume":"18","author":"BT Post","year":"1988","unstructured":"Post BT, Philbrick JT: Do corticosteroids prevent postherpetic neuralgia? J Am Acad Dermatol 1988, 18:605\u2013610.","journal-title":"J Am Acad Dermatol"},{"key":"66_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199403313301304","volume":"330","author":"MJ Wood","year":"1994","unstructured":"Wood MJ, Johnson RW, McKendrick MW, et al.: A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994, 330:896\u2013900.","journal-title":"N Engl J Med"},{"key":"66_CR34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","volume":"125","author":"RJ Whitley","year":"1996","unstructured":"Whitley RJ, Weiss H, Gnann JW Jr, et al.: Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996, 125:376\u2013383.","journal-title":"Ann Intern Med"},{"key":"66_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al.: Neurologic complications of the reactivation of varicellazoster virus. N Engl J Med 2000, 342:635\u2013645.","journal-title":"N Engl J Med"},{"key":"66_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0885-3924(97)00077-8","volume":"13","author":"D Bowsher","year":"1997","unstructured":"Bowsher D: The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997, 13:327\u2013331. This paper provides the evidence for the use of amitriptyline in preventing PHN.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR37","unstructured":"Varivax (Varicella Virus Vaccine Live [Oka\/Merck]). In Physician\u2019s Desk Reference, edn 52. Montvale, NJ: Medical Economics; 1998:1762-1765."},{"issue":"suppl 1","key":"66_CR38","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1086\/514264","volume":"178","author":"MJ Levin","year":"1998","unstructured":"Levin MJ, Barber D, Goldblatt E, et al.: Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998, 178(suppl 1):S109\u2013112.","journal-title":"J Infect Dis"},{"key":"66_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1155\/1999\/961273","volume":"4","author":"CPN Watson","year":"1999","unstructured":"Watson CPN, Watt-Watson JH: Treatment of neuropathic pain: focus on antidepressants, opioids and gabapentin. Pain Res Manage 1999, 4:168\u2013178.","journal-title":"Pain Res Manage"},{"key":"66_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(91)90004-H","volume":"47","author":"RC Kupers","year":"1991","unstructured":"Kupers RC, Konings H, Adriaenson H, Gybels JM: Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991, 47:5\u201312.","journal-title":"Pain"},{"key":"66_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","volume":"33","author":"S Arner","year":"1988","unstructured":"Arner S, Meyerson BA: Lack of analgesic effect of opioids on neuropathic pain and idiopathic forms of pain. Pain 1988, 33:11\u201323.","journal-title":"Pain"},{"key":"66_CR42","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","volume":"50","author":"CPN Watson","year":"1998","unstructured":"Watson CPN, Babul N: Efficacy of oxycodone in neuropathic pain\u2014a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837\u20131841.","journal-title":"Neurology"},{"key":"66_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(96)09024-1","volume":"349","author":"PLI Dellemijn","year":"1997","unstructured":"Dellemijn PLI, Vanneste JAL: Randomized double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997, 349:753\u2013758.","journal-title":"Lancet"},{"key":"66_CR44","first-page":"217","volume":"39","author":"JJ Menke","year":"1999","unstructured":"Menke JJ, Heins JR: Treatment of postherpetic neuralgia. J Am Pharm Assoc 1999, 39:217\u2013221.","journal-title":"J Am Pharm Assoc"},{"key":"66_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(95)00155-7","volume":"65","author":"G De Benedittis","year":"1996","unstructured":"De Benedittis G, Lorenzetti A: Topical aspirin\/diethyl ether mixture versus indomethacin and diclofenac\/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996, 65:45\u201351.","journal-title":"Pain"},{"key":"66_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s002280050451","volume":"54","author":"SR Bareggi","year":"1998","unstructured":"Bareggi SR, Pirola R, De Benedittis G: Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin\/ diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia. Eur J Clin Pharmacol 1998, 54:231\u2013235.","journal-title":"Eur J Clin Pharmacol"},{"key":"66_CR47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0304-3959(98)00244-9","volume":"80","author":"BS Galer","year":"1999","unstructured":"Galer BS, Rowbotham MC, Perander J, Friedman E: Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999, 80:533\u2013538.","journal-title":"Pain"},{"key":"66_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.1999.tb03501.x","volume":"26","author":"A Ozawa","year":"1999","unstructured":"Ozawa A, Haruki Y, Iwashita K, et al.: Follow-up of clinical efficacy of iontophoresis therapy for postherpetic neuralgia (PHN). J Dermatol 1999, 26:1\u201310.","journal-title":"J Dermatol"},{"key":"66_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.32.6.671","volume":"32","author":"CPN Watson","year":"1982","unstructured":"Watson CPN, Evans RJ, Reed K, et al.: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32:671\u2013673.","journal-title":"Neurology"},{"key":"66_CR50","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","volume":"51","author":"CPN Watson","year":"1998","unstructured":"Watson CPN, Vernich L, Chipman M, Reed K: Nortriptyline versus amitriptyline in postherpetic neuralgia\u2014a randomized trial. Neurology 1998, 51:1166\u20131171.","journal-title":"Neurology"},{"key":"66_CR51","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","volume":"280","author":"M Rowbotham","year":"1998","unstructured":"Rowbotham M, Harden M, Stacey B, et al.: Gabapentin for the treatment of postherpetic neuralgia\u2014a randomized controlled trial. JAMA 1998, 280:1837\u20131842. A landmark paper establishing the role of gabapentin in the management of PHN.","journal-title":"JAMA"},{"key":"66_CR52","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/archderm.135.11.1359","volume":"135","author":"SM Hwang","year":"1999","unstructured":"Hwang SM, Kang YC, Lee YB, et al.: The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol 1999, 135:1359\u20131364.","journal-title":"Arch Dermatol"},{"key":"66_CR53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/archderm.134.3.279","volume":"134","author":"SE Chiarello","year":"1998","unstructured":"Chiarello SE: Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol 1998, 134:279\u2013281.","journal-title":"Arch Dermatol"},{"key":"66_CR54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-4362.1998.00392.x","volume":"37","author":"R Bhargava","year":"1998","unstructured":"Bhargava R, Bhargava S, Haldia KN, Bhargava P: Jaipur block in postherpetic neuralgia. Int J Dermatol 1998, 37:465\u2013468.","journal-title":"Int J Dermatol"},{"key":"66_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF03006847","volume":"27","author":"JB Forrest","year":"1980","unstructured":"Forrest JB: The response to epidural steroid injection in chronic dorsal root pain. Can Anaesth Soc J 1980,27:40\u201346.","journal-title":"Can Anaesth Soc J"},{"key":"66_CR56","first-page":"287","volume":"24","author":"A Kikuchi","year":"1999","unstructured":"Kikuchi A, Kotani N, Sato T, et al.: Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for lont-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999, 24:287\u2013293.","journal-title":"Reg Anesth Pain Med"},{"key":"66_CR57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1399-6576.1997.tb04709.x","volume":"41","author":"P Klepstad","year":"1997","unstructured":"Klepstad P, Borchgrevink PC: Four years\u2019 treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Acta Anesthiol Scand 1997, 41:422\u2013426.","journal-title":"Acta Anesthiol Scand"},{"key":"66_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0304-3959(94)00182-E","volume":"61","author":"PK Eide","year":"1995","unstructured":"Eide PK, Stubbaug A, Oye I, Breivik H: Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain 1995, 61:221\u2013228.","journal-title":"Pain"},{"key":"66_CR59","first-page":"151","volume":"34","author":"C Wong","year":"1996","unstructured":"Wong C, Shen T, Liaw W, et al.: Epidural coadministration of ketamine, morphine and bupivacaine attenuates postherpetic neuralgia: a case report. Acta Anaesthesiol Sin 1996, 34:151\u2013155.","journal-title":"Acta Anaesthesiol Sin"},{"key":"66_CR60","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1227\/00006123-198412000-00041","volume":"15","author":"AH Friedman","year":"1984","unstructured":"Friedman AH, Nashold BS: Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. Neurosurgery 1984, 15:969\u2013970.","journal-title":"Neurosurgery"},{"key":"66_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF01420297","volume":"138","author":"SA Rath","year":"1996","unstructured":"Rath SA, Braun V, Soliman N, et al.: Results of DREZ coagulations for pain related to plexus lesions, spinal cord injuries and postherpetic neuralgia. Acta Neurochir 1996, 138:364\u2013369.","journal-title":"Acta Neurochir"}],"container-title":["Current Review of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-000-0066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-000-0066-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-000-0066-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-000-0066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:35:05Z","timestamp":1659094505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-000-0066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11916-000-0066-7","relation":{},"ISSN":["1069-5850"],"issn-type":[{"value":"1069-5850","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"1 December 2000","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}